Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Oric Pharmaceuticals Inc stock
Learn how to easily invest in Oric Pharmaceuticals Inc stock.
Oric Pharmaceuticals Inc is a biotechnology business based in the US. Oric Pharmaceuticals Inc shares (ORIC) are listed on the NASDAQ and all prices are listed in US Dollars. Oric Pharmaceuticals Inc employs 79 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Oric Pharmaceuticals Inc
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ORIC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Oric Pharmaceuticals Inc stock price (NASDAQ: ORIC)Use our graph to track the performance of ORIC stocks over time.
Oric Pharmaceuticals Inc shares at a glance
|Latest market close||$4.86|
|52-week range||$2.62 - $26.70|
|50-day moving average||$3.66|
|200-day moving average||$10.93|
|Wall St. target price||$12.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.21|
Buy Oric Pharmaceuticals Inc shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Oric Pharmaceuticals Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Oric Pharmaceuticals Inc price performance over time
|1 week (2022-06-23)||9.71%|
|1 month (2022-05-26)||N/A|
|3 months (2022-03-28)||-7.07%|
|6 months (2021-12-30)||-68.83%|
|1 year (2021-06-30)||-72.53%|
|2 years (2020-06-30)||-85.59%|
|3 years (2019-06-26)||N/A|
|5 years (2017-06-26)||N/A|
Oric Pharmaceuticals Inc financials
|Gross profit TTM||$0|
|Return on assets TTM||-19.14%|
|Return on equity TTM||-32.27%|
|Market capitalisation||$174.9 million|
TTM: trailing 12 months
Oric Pharmaceuticals Inc share dividends
We're not expecting Oric Pharmaceuticals Inc to pay a dividend over the next 12 months.
Oric Pharmaceuticals Inc share price volatility
Over the last 12 months, Oric Pharmaceuticals Inc's shares have ranged in value from as little as $2.62 up to $26.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oric Pharmaceuticals Inc's is 2.362. This would suggest that Oric Pharmaceuticals Inc's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Oric Pharmaceuticals Inc overview
ORIC Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc. ; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Oric Pharmaceuticals Inc in the news
ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference
ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference
Frequently asked questionsWhat percentage of Oric Pharmaceuticals Inc is owned by insiders or institutions?
Currently 3.934% of Oric Pharmaceuticals Inc shares are held by insiders and 88.966% by institutions. How many people work for Oric Pharmaceuticals Inc?
Latest data suggests 79 work at Oric Pharmaceuticals Inc. When does the fiscal year end for Oric Pharmaceuticals Inc?
Oric Pharmaceuticals Inc's fiscal year ends in December. Where is Oric Pharmaceuticals Inc based?
Oric Pharmaceuticals Inc's address is: 240 East Grand Avenue, South San Francisco, CA, United States, 94080 What is Oric Pharmaceuticals Inc's ISIN number?
Oric Pharmaceuticals Inc's international securities identification number is: US68622P1093 What is Oric Pharmaceuticals Inc's CUSIP number?
Oric Pharmaceuticals Inc's Committee on Uniform Securities Identification Procedures number is: 68622P109
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert